Mirum Pharmaceuticals (mirm 4 05/01/29)
13F holders, Q4 2024 (December 31)3holders −1
0new positions
1sold out
$1.52avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Mirum Pharmaceuticals (mirm 4 05/01/29) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Sei Investments Co. ($347K), Oppenheimer Asset Management Inc. ($94K) and Stephens Inc. ($29K).
- Company
- Mirum Pharmaceuticals (mirm 4 05/01/29)
- CUSIP
- 604749AB7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 45,000 shares sold, net −45,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Sei Investments Co. | 0.00% | Reduce -8.4% | 228,000 | $347K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -7.5% | 62,000 | $94K |
| Stephens Inc. | 0.00% | Reduce -47.2% | 19,000 | $29K |
"% of holder's portfolio" is MIRUM PHARMACEUTICALS (MIRM 4 05/01/29)'s weight in each manager's 13F, not the share of Mirum Pharmaceuticals (mirm 4 05/01/29) the manager owns.